BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 12807348)

  • 21. Efficacy of Ginkgo biloba extract EGb 761
    von Gunten A; Schlaefke S; Überla K
    World J Biol Psychiatry; 2016 Dec; 17(8):622-633. PubMed ID: 26223956
    [TBL] [Abstract][Full Text] [Related]  

  • 22. EGb 761: ginkgo biloba extract, Ginkor.
    Drugs R D; 2003; 4(3):188-93. PubMed ID: 12757407
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Salvia officinalis extract in the treatment of patients with mild to moderate Alzheimer's disease: a double blind, randomized and placebo-controlled trial.
    Akhondzadeh S; Noroozian M; Mohammadi M; Ohadinia S; Jamshidi AH; Khani M
    J Clin Pharm Ther; 2003 Feb; 28(1):53-9. PubMed ID: 12605619
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Value of Ginkgo biloba in treatment of Alzheimer dementia].
    Loew D
    Wien Med Wochenschr; 2002; 152(15-16):418-22. PubMed ID: 12244890
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ginkgo and Alzheimer's disease: little or no different from placebo.
    Prescrire Int; 2007 Oct; 16(91):205-7. PubMed ID: 17926840
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gingko biloba extract EGb 761®: clinical data in dementia.
    Ihl R
    Int Psychogeriatr; 2012 Aug; 24 Suppl 1():S35-40. PubMed ID: 22784427
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of Ginkgo biloba Extract EGb 761, Donepezil and their Combination on Central Cholinergic Function in Aged Rats.
    Stein C; Hopfeld J; Lau H; Klein J
    J Pharm Pharm Sci; 2015; 18(4):634-46. PubMed ID: 26626253
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cholinesterase inhibitors in the treatment of Alzheimer's disease: a comparison of tolerability and pharmacology.
    Nordberg A; Svensson AL
    Drug Saf; 1998 Dec; 19(6):465-80. PubMed ID: 9880090
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of Ginkgo biloba extract EGb 761 on neuropsychiatric symptoms of dementia: findings from a randomised controlled trial.
    Scripnikov A; Khomenko A; Napryeyenko O;
    Wien Med Wochenschr; 2007; 157(13-14):295-300. PubMed ID: 17704975
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical efficacy of Ginkgo biloba special extract EGb 761 in dementia of the Alzheimer type.
    Maurer K; Ihl R; Dierks T; Frölich L
    J Psychiatr Res; 1997; 31(6):645-55. PubMed ID: 9447569
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy of rivastigmine in comparison to ginkgo for treating Alzheimer's dementia.
    Nasab NM; Bahrammi MA; Nikpour MR; Rahim F; Naghibis SN
    J Pak Med Assoc; 2012 Jul; 62(7):677-80. PubMed ID: 23866514
    [TBL] [Abstract][Full Text] [Related]  

  • 32.
    Spiegel R; Kalla R; Mantokoudis G; Maire R; Mueller H; Hoerr R; Ihl R
    Clin Interv Aging; 2018; 13():1121-1127. PubMed ID: 29942120
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ginkgo biloba compared with cholinesterase inhibitors in the treatment of dementia: a review based on meta-analyses by the cochrane collaboration.
    Kurz A; Van Baelen B
    Dement Geriatr Cogn Disord; 2004; 18(2):217-26. PubMed ID: 15237280
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy and safety of a once-daily formulation of Ginkgo biloba extract EGb 761 in dementia with neuropsychiatric features: a randomized controlled trial.
    Ihl R; Bachinskaya N; Korczyn AD; Vakhapova V; Tribanek M; Hoerr R; Napryeyenko O;
    Int J Geriatr Psychiatry; 2011 Nov; 26(11):1186-94. PubMed ID: 21140383
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of dementia and mild cognitive impairment with or without cerebrovascular disease: Expert consensus on the use of Ginkgo biloba extract, EGb 761
    Kandiah N; Ong PA; Yuda T; Ng LL; Mamun K; Merchant RA; Chen C; Dominguez J; Marasigan S; Ampil E; Nguyen VT; Yusoff S; Chan YF; Yong FM; Krairit O; Suthisisang C; Senanarong V; Ji Y; Thukral R; Ihl R
    CNS Neurosci Ther; 2019 Feb; 25(2):288-298. PubMed ID: 30648358
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ginkgo biloba special extract EGb 761 in the treatment of peripheral arterial occlusive disease (PAOD)--a review based on randomized, controlled studies.
    Horsch S; Walther C
    Int J Clin Pharmacol Ther; 2004 Feb; 42(2):63-72. PubMed ID: 15180165
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ginkgo biloba extract EGb 761® in the context of current developments in the diagnosis and treatment of age-related cognitive decline and Alzheimer's disease: a research perspective.
    Lautenschlager NT; Ihl R; Müller WE
    Int Psychogeriatr; 2012 Aug; 24 Suppl 1():S46-50. PubMed ID: 22784429
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Ginkgo biloba extract (EGb 761). State of knowledge in the dawn of the year 2000].
    Clostre F
    Ann Pharm Fr; 1999 Jul; 57 Suppl 1():1S8-88. PubMed ID: 10481350
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A double-blind, placebo-controlled, randomized trial of Ginkgo biloba extract EGb 761 in a sample of cognitively intact older adults: neuropsychological findings.
    Mix JA; Crews WD
    Hum Psychopharmacol; 2002 Aug; 17(6):267-77. PubMed ID: 12404671
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.